The Power Of AI To Transform Clinical Trials
Source: ICON Plc
Artificial intelligence (AI) technology, combined with big data, hold the potential to solve many key clinical trial challenges.
These include increasing trial efficiency through better protocol design, patient enrolment and retention, and study start-up, which were each named as prime candidates for improvement by nearly 40 percent of sponsors in a recent ICON-Pharma Intelligence survey. With clinical trials accounting for 40 percent of pharma research budgets, sponsors need new ways to accelerate timelines and reduce costs.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more